Major investors initiate secondary issuance, Medline stock price drops 4.4%

LootboxPhobia · 2026-03-03T20:13:33+00:00

On Tuesday, Medline Industries Inc's stock price fell 4.4% to $43.84, as its major shareholders announced a secondary offering of 75 million shares, including Blackstone Group, Carlyle Group, Hellman & Friedman, and Abu Dhabi Investment Authority. The offering is led by Goldman Sachs and other global coordinators.

LootboxPhobia

2026-03-03 20:13:33

Abstract generation in progress

Investing.com – During pre-market trading on Tuesday, Medline Industries Inc (NYSE:MDLN) stock fell 4.4% to $43.84 after the medical supplies company announced that its major shareholders will conduct a secondary offering of 75 million shares.

Selling shareholders include Blackstone Group (NYSE:BX), Carlyle Group (NASDAQ:CG), Hellman & Friedman, and Abu Dhabi Investment Authority.

Blackstone, Carlyle, and Hellman & Friedman each sold 23.3 million shares, while Abu Dhabi Investment Authority provided approximately 5.1 million shares.

Goldman Sachs, Morgan Stanley, Bank of America Securities, and J.P. Morgan acted as global coordinators and joint bookrunners for the offering.

According to the prospectus, Medline has 1.31 billion shares outstanding.

Headquartered in Northfield, Illinois, the company went public in New York last December, marking the largest IPO in 2025.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.